Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2003
10/29/2003CN1125877C Hepatitis G. Virus and molecular cloning thereof
10/29/2003CN1125826C Hepatitis E virus gene sequence and its application
10/28/2003US6639063 Signal peptide directs the secretion of a polypeptide when located at the amino terminus of a polypeptide
10/28/2003US6639060 DNA segment encoding a receptor protein related to the erbB proto-oncogene family which previously has not been known; tool for screening for anticancer agents
10/28/2003US6639057 Monoclonal antibody against human telomerase catalytic subunit
10/28/2003US6639056 Antibodies specifically reactive with integrin β6 subunits
10/28/2003US6639055 Method for making humanized antibodies
10/28/2003US6638751 Isolated human zinc protease proteins
10/28/2003US6638747 Isolated polypeptide having specified amino acid sequence
10/28/2003US6638736 Gene expression inhibition; cancer and neurodegenerative disease diagnosis; molecular hybridization
10/28/2003US6638731 Nucleotide sequences coding preferential polypeptide for use in diagnosis and treatment of alzheimer's disease
10/28/2003US6638511 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
10/28/2003US6638510 Recombinant plasmid and a method of controlling the effects of Yersinia pestis
10/28/2003US6638507 Antigen binding site of antibody; encoded by nucleic acids; diagnostic kits
10/28/2003US6638506 Detecting for mononucleic cells
10/28/2003US6638505 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer
10/28/2003US6638504 Methods for treating cancer
10/28/2003CA2118010C Antibodies specific for carcinoma-associated antigens
10/23/2003WO2003088650A1 Digital camera
10/23/2003WO2003087841A2 An ephrin-b receptor protein involved in carcinoma
10/23/2003WO2003087840A2 Protein involved in cancer
10/23/2003WO2003087838A2 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (mbl)
10/23/2003WO2003087832A2 Diagnosis of carcinoma using raigi polypeptides
10/23/2003WO2003087818A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
10/23/2003WO2003087400A1 Methods and reagents for assaying protein kinase activity
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087363A1 Cancer-associated gene mina 53, protein mina 53 and monoclonal antibody thereof
10/23/2003WO2003087356A2 Helicokinin-receptor from insects
10/23/2003WO2003087340A2 Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof
10/23/2003WO2003087338A2 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003WO2003087324A2 Antibody gene transfer and recombinant aav
10/23/2003WO2003087306A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003WO2003087163A1 METHOD OF CONSTRUCTING scDb LIBRARY
10/23/2003WO2003087134A2 G-protein coupled receptor ligands and methods
10/23/2003WO2003087131A2 Anti-her2 antibody variants
10/23/2003WO2003087129A2 Immunogenic peptides, and method of identifying same
10/23/2003WO2003086473A1 Mycoplasma polypeptides
10/23/2003WO2003086472A1 Drugs to be used in gene therapy for recessively transmitted genetic disease
10/23/2003WO2003086463A1 Remedies for pemphigus containing cd40l antagonist as the active ingredient
10/23/2003WO2003086459A1 Methods of treatement using ctla-4 antibodies
10/23/2003WO2003086458A1 Recombinant anti-interleukin-9 antibodies
10/23/2003WO2003086457A2 Method of treating or preventing autoimmune disease
10/23/2003WO2003086456A2 Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer
10/23/2003WO2003086451A1 Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses
10/23/2003WO2003086311A2 Methods for treating tweak-related conditions
10/23/2003WO2003086310A2 Prevention of brain inflammation as a result of induced autoimmune response
10/23/2003WO2003086308A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003WO2003086307A2 β2-MICROGLOBILIN (β2m) AND ANTI-β2m BINDING AGENTS AS ANTI-CANCER THERAPEUTICS
10/23/2003WO2003086301A2 Antibodies that specifically bind to tr2
10/23/2003WO2003086300A2 Methods and compositions for treating alzheimer's disease
10/23/2003WO2003086296A2 Treatment for type 1 diabetes before and after expression of predisposition markers.
10/23/2003WO2003086289A2 Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors
10/23/2003WO2003086286A2 Treatment of type 1 diabetes before and after expression of predisposition markers
10/23/2003WO2003086175A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/23/2003WO2003086041A2 Binding agents and their use in targeting tumor cells
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003054005A3 Bone polypeptide-1
10/23/2003WO2003048317A3 Antibodies to magmas and uses thereof
10/23/2003WO2003040164A3 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
10/23/2003WO2003031466A3 Angiotensin peptide-carrier conjugates and uses thereof
10/23/2003WO2003020875A3 Staphylococci surface-exposed immunogenic polypeptides
10/23/2003WO2003016466A3 ANTI-Aβ ANTIBODIES
10/23/2003WO2003011908A3 Mutant forms of the tgf-b type ii receptor which bind all tgf-b isoforms and the use thereof
10/23/2003WO2003010201A3 Blood group antigen fusion polypeptides and methods of use thereof
10/23/2003WO2003005888A3 Lipophilin complexes for use in cancer diagnosis and therapy
10/23/2003WO2003000883A1 Cell proliferation inhibitors containing anti-glypican 3 antibody
10/23/2003WO2002102312A3 Combination therapy of gamma-interferon and b cell specific antibodies
10/23/2003WO2002100326A3 Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies
10/23/2003WO2002099099A3 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
10/23/2003WO2002097042A3 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
10/23/2003WO2002092015A3 Reagents and methods for modulating dkk-mediated interactions
10/23/2003WO2002077216A3 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/23/2003WO2002068589A3 Enzymes having alpha amylase activity and methods of use thereof
10/23/2003WO2002066494A8 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
10/23/2003WO2002055700A3 Human genes and gene expression products isolated from human prostate
10/23/2003WO2002047720A3 Treatment and prevention of ebv infection and ebv-associated disorders
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2002044336B1 Method of making a protein polymer and uses of the polymer
10/23/2003WO2001096376A9 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
10/23/2003WO2001068805A3 Human olfactory receptors and genes encoding same
10/23/2003WO2001055337A9 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/23/2003WO2001040519A8 Methods for identifying modulators for balance related disorders
10/23/2003WO2001009328A8 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/23/2003WO2001005427A8 Psca: prostate stem cell antigen and uses thereof
10/23/2003WO2001002567A8 16405 receptor, a g-protein coupled receptor
10/23/2003WO2001000879A8 Novel kinases and uses thereof
10/23/2003WO2001000812A8 22012, a novel human carboxypeptidase
10/23/2003WO2001000811A8 17867, a novel human aminopeptidase
10/23/2003US20030200555 For Alzheimer's disease diagnosis, treatment
10/23/2003US20030199679 Recombinant antibodies specific for TNF-alpha
10/23/2003US20030199678 Such that binding modifies TNF activity
10/23/2003US20030199675 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199674 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/23/2003US20030199673 For inducing immune response and administering immunotherapy
10/23/2003US20030199671 For protein isolation and purification
10/23/2003US20030199464 Regeneration of endogenous myocardial tissue by induction of neovascularization
10/23/2003US20030199452 Antigenic peptides reacting with anti-ovary antibodies
10/23/2003US20030199437 Identification, isolation and recombinant production of novel DNA; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules; fused heterologous polypeptide sequences, binding antibodies; anticarcinogenic
10/23/2003US20030199436 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 ... 1494